PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
17.44%
Revenue growth under 50% of BIDU's 184.07%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
18.00%
Gross profit growth under 50% of BIDU's 170.95%. Michael Burry would be concerned about a severe competitive disadvantage.
30.38%
EBIT growth below 50% of BIDU's 187.98%. Michael Burry would suspect deeper competitive or cost structure issues.
30.38%
Operating income growth under 50% of BIDU's 187.98%. Michael Burry would be concerned about deeper cost or sales issues.
59.13%
Net income growth under 50% of BIDU's 211.39%. Michael Burry would suspect the firm is falling well behind a key competitor.
-25.19%
Negative EPS growth while BIDU is at 184.62%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-23.51%
Negative diluted EPS growth while BIDU is at 184.62%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
6.30%
Share reduction more than 1.5x BIDU's 37.19%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
10.11%
Diluted share reduction more than 1.5x BIDU's 37.19%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
25.27%
OCF growth of 25.27% while BIDU is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
16.30%
FCF growth of 16.30% while BIDU is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
3935.36%
10Y revenue/share CAGR above 1.5x BIDU's 313.32%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
3935.36%
5Y revenue/share CAGR above 1.5x BIDU's 313.32%. David Dodd would look for consistent product or market expansions fueling outperformance.
667.10%
3Y revenue/share CAGR above 1.5x BIDU's 313.32%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
518.61%
3Y OCF/share CAGR of 518.61% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
5467.63%
Net income/share CAGR above 1.5x BIDU's 591.07% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
5467.63%
5Y net income/share CAGR above 1.5x BIDU's 591.07%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
1830.65%
3Y net income/share CAGR above 1.5x BIDU's 591.07%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.73%
Our AR growth while BIDU is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
9.96%
Similar asset growth to BIDU's 9.87%. Walter Schloss finds parallel expansions or investment rates.
2.31%
Positive BV/share change while BIDU is negative. John Neff sees a clear edge over a competitor losing equity.
No Data
No Data available this quarter, please select a different quarter.
57.00%
R&D dropping or stable vs. BIDU's 175.10%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
10.20%
SG&A declining or stable vs. BIDU's 100.00%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.